This result is not consistent with the mechanism of action of TNF-α, and the analysis may be due to the fact that the dose and duration of action of GSP used in this trial are not sufficient, so the effect on the large amount of TNF-α produced by obesity is not obvious. The gene discussed is TNF; the disease is obesity disorder.